
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients
Author(s) -
Abraham Rutgers,
Peter E. Westerweel,
Bronno van der Holt,
Simone Postma,
Marit G. A. van Vonderen,
Djura Piersma,
Douwe F. Postma,
Maarten van den Berge,
Eefje Jong,
Marten de Vries,
Leonie van der Burg,
Dennis Huugen,
Marjolein van der Poel,
Linda M. Kampschreur,
Marcel Nijland,
J.H. Strijbos,
Menno Tamminga,
Pim Mutsaers,
Suzanne Schol-Gelok,
Margriet J. DijkstraTiekstra,
Grigory Sidorenkov,
Julien Vincenten,
Wouter H. van Geffen,
Marjolein Knoester,
Jos Kosterink,
Rijk O. B. Gans,
Coen A. Stegeman,
Gerwin Huls,
Tom van Meerten
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0271807
Subject(s) - tocilizumab , medicine , clinical endpoint , mechanical ventilation , hazard ratio , randomized controlled trial , surgery , confidence interval , disease